DIA 2015 Editor’s Take – WIRB-Copernicus Group

Thought Leader:

Dr. Donald A. Deieso, Ph.D., Chairman and CEO, WIRB-Copernicus Group

July 29, 2015      

Dr. Deieso discusses the most significant changes in drug development, new opportunities, and how precision medicine is impacting adaptive trials.

For more information please visit www.wcgclinical.com/.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK